HPE
55
11
KR
34
-3
SO
55
-2
M
20
-4
MRO
55
3
MAS
51
4
FLS
73
-2
AIV
68
-4
CVX
46
5
SRE
63
-3
ORLY
53
-3
PRU
57
-3
PNW
66
3
HP
38
-2
DVN
16
3
FDX
36
-4
DHR
35
3
ACN
47
-2
URI
53
-2
EL
20
3
HPE
55
11
KR
34
-3
SO
55
-2
M
20
-4
MRO
55
3
MAS
51
4
FLS
73
-2
AIV
68
-4
CVX
46
5
SRE
63
-3
ORLY
53
-3
PRU
57
-3
PNW
66
3
HP
38
-2
DVN
16
3
FDX
36
-4
DHR
35
3
ACN
47
-2
URI
53
-2
EL
20
3
Financhill
Back

Bioxytran Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34

BIXT
Bioxytran

Last Price:
0.1000
Seasonality Move:
509.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Bioxytran Price Quote

$0.1000
+0.0013 (+2.88%)
(Updated: November 22, 2024 at 2:59 AM ET)

Bioxytran Key Stats

Sell
34
Bioxytran (BIXT) is a Sell
Day range:
$0.0987 - $0.0987
52-week range:
$0.0710 - $0.1740
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
69.83
P/B ratio:
0%
Volume:
1.9K
Avg. volume:
84.9K
1-year change:
-28.22%
Market cap:
$8.5M
Revenue:
$0
EPS:
$-0.01

How Much Does Bioxytran Make?

Data Unavailable

Is Bioxytran Growing As A Company?

Data Unavailable

Bioxytran Stock Price Performance

  • Did Bioxytran Stock Go Up Last Month?
    Bioxytran share price went down by -8.67% last month
  • Did BIXT's Share Price Rise Over The Last Year?
    BIXT share price fell by -28.22% over the past 1 year

What Is Bioxytran 52-Week High & Low?

  • What Is Bioxytran’s 52-Week High Share Price?
    Bioxytran has traded as high as $0.1740 over the past 52 weeks
  • What Is Bioxytran’s 52-Week Low Share Price?
    Bioxytran has traded as low as $0.0710 over the past 52 weeks

Bioxytran Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bioxytran?

  • How Much Debt Does Bioxytran Have?
    Total long term debt quarterly is $0
  • How Much Cash Does Bioxytran Have?
    Cash and short term investments quarterly total is $34.7K
  • What Is Bioxytran’s Book Value Per Share?
    Book value per share is -0.01

Is Bioxytran Cash Flow Positive?

  • What Is BIXT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$190.7K
  • What Is Bioxytran’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $169.5K
  • What Is Bioxytran’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$24.4K

Bioxytran Return On Invested Capital

Data Unavailable

Bioxytran Earnings Date & Stock Price

  • What Is Bioxytran's Stock Price Today?
    A single share of BIXT can be purchased today for 0.0987
  • What Is Bioxytran’s Stock Symbol?
    Bioxytran trades on the otcm under the ticker symbol: BIXT
  • When Is Bioxytran’s Next Earnings Date?
    The next quarterly earnings date for Bioxytran is scheduled on April 22, 2025
  • When Is BIXT's next ex-dividend date?
    Bioxytran's next ex-dividend date is November 22, 2024
  • How To Buy Bioxytran Stock?
    You can buy Bioxytran shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Bioxytran Competitors

  • Who Are Bioxytran's Competitors?
    Below is a list of companies who compete with Bioxytran or are related in some way:
    • Aethlon Medical Inc (AEMD)
    • Gossamer Bio Inc (GOSS)
    • iBio Inc (IBIO)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)

Bioxytran Dividend Yield

  • What Is BIXT Dividend Yield?
    Bioxytran’s dividend yield currently is 0%
  • What Is Bioxytran’s Payout Ratio?
    Bioxytran’s payout ratio is 0%
  • When Did Bioxytran Last Pay A Dividend?
    The latest dividend pay date is November 22, 2024
  • What Is Bioxytran’s Dividend Per Share?
    Bioxytran pays a dividend of $0.0000 per share

Bioxytran Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.0000
Downside from Last Price: -100%

Major Shareholders

Data Unavailable